🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several professionals said the demand for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.

Service Response and Material Removal

Based on the social media company, the platform has removed violative material and prohibited related hashtags and search suggestions. The organization stated it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, posts show black plastic packages with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service stated it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially serious health risks”.